Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Epigenetics"
DOI: 10.1186/s13148-018-0540-x
Abstract: BackgroundPrognostic tools for prostate cancer (PC) are inadequate and new molecular biomarkers may improve risk stratification. The epigenetic mark 5-hydroxymethylcytosine (5hmC) has recently been proposed as a novel candidate prognostic biomarker in several malignancies including…
read more here.
Keywords:
formylcytosine 5fc;
hydroxymethylcytosine 5hmc;
5cac levels;
prostate cancer ... See more keywords